Cargando…

Selective inhibition of protein targeting to the apical domain of MDCK cells by brefeldin A

Dipeptidyl peptidase IV (DPPIV) is mainly vectorially targeted to the apical surface in MDCK cells. BFA was found to abolish the apical targeting of DPPIV. This BFA effect could be achieved under conditions where the ER to Golgi transport and the total surface expression of DPPIV were essentially un...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1992
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2289512/
https://www.ncbi.nlm.nih.gov/pubmed/1352300
_version_ 1782152274726879232
collection PubMed
description Dipeptidyl peptidase IV (DPPIV) is mainly vectorially targeted to the apical surface in MDCK cells. BFA was found to abolish the apical targeting of DPPIV. This BFA effect could be achieved under conditions where the ER to Golgi transport and the total surface expression of DPPIV were essentially unaffected. BFA executed its effect during the transport from the trans-Golgi network (TGN) to the surface. The inhibition of apical targeting resulted in enhanced mis-targeting to the basolateral surface. The mistargeted DPPIV was transcytosed back to the apical domain only after BFA withdrawal. In contrast, the basolateral targeting of uvomorulin was unaffected by BFA. These results established that the apical targeting of DPPIV was selectively abolished by BFA.
format Text
id pubmed-2289512
institution National Center for Biotechnology Information
language English
publishDate 1992
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22895122008-05-01 Selective inhibition of protein targeting to the apical domain of MDCK cells by brefeldin A J Cell Biol Articles Dipeptidyl peptidase IV (DPPIV) is mainly vectorially targeted to the apical surface in MDCK cells. BFA was found to abolish the apical targeting of DPPIV. This BFA effect could be achieved under conditions where the ER to Golgi transport and the total surface expression of DPPIV were essentially unaffected. BFA executed its effect during the transport from the trans-Golgi network (TGN) to the surface. The inhibition of apical targeting resulted in enhanced mis-targeting to the basolateral surface. The mistargeted DPPIV was transcytosed back to the apical domain only after BFA withdrawal. In contrast, the basolateral targeting of uvomorulin was unaffected by BFA. These results established that the apical targeting of DPPIV was selectively abolished by BFA. The Rockefeller University Press 1992-07-01 /pmc/articles/PMC2289512/ /pubmed/1352300 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Selective inhibition of protein targeting to the apical domain of MDCK cells by brefeldin A
title Selective inhibition of protein targeting to the apical domain of MDCK cells by brefeldin A
title_full Selective inhibition of protein targeting to the apical domain of MDCK cells by brefeldin A
title_fullStr Selective inhibition of protein targeting to the apical domain of MDCK cells by brefeldin A
title_full_unstemmed Selective inhibition of protein targeting to the apical domain of MDCK cells by brefeldin A
title_short Selective inhibition of protein targeting to the apical domain of MDCK cells by brefeldin A
title_sort selective inhibition of protein targeting to the apical domain of mdck cells by brefeldin a
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2289512/
https://www.ncbi.nlm.nih.gov/pubmed/1352300